This course will highlight current imaging modalities, emerging therapies, and leading trends in the treatment and management of retinal vascular disease including age-related macular degeneration, retinal vascular occlusive disease, and diabetic eye disease.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Understand the clinically relevant pathophysiology of diabetic eye disease, age-related macular degeneration, and retinal vascular occlusive disease
Evaluate key clinical and ancillary testing features of retinal vascular disease
Evaluate the basis for current and emerging therapies utilized in the management of retinal vascular disease
Apply the results of pertinent clinical trial to clinical practice
Disclosure(s):
Jessica Steen, OD: AbbVie/Allergan: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Alcon: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Astellas: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bausch + Lomb: Consulting Fees (); Carl Zeiss Meditec: Consulting Fees (); Clearside Biomedical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); iCare: Advisory Committee/Board Member (); Ocuphire: Advisory Committee/Board Member (); Ocuterra: Advisory Committee/Board Member (); Peripherex: Advisory Committee/Board Member (); Radius XR: Advisory Committee/Board Member (); Santen: Advisory Committee/Board Member (); Viatris: Consulting Fees ()
